Collicaid Syrup is NOT Recommended for Pediatric Use
Collicaid should not be used in children under 6 years of age, and there is no established safe or effective oral syrup dosing for pediatric patients. 1
Critical Safety Information
The FDA-approved labeling for Collicaid explicitly states:
- "Children under 6 years of age: do not use, ask a doctor" 1
- Collicaid is formulated as a topical product only, intended to be "applied to affected area not more than 3 times daily" 1
- This is a topical treatment for urushiol exposure (poison ivy/oak reactions), not an oral medication 1
Important Clinical Clarification
There appears to be confusion about this product. The available evidence indicates Collicaid is a topical dermatological preparation, not an oral syrup formulation. 1 If you are seeking dosing information for a different pediatric medication:
- Verify the correct generic name and indication
- Confirm the route of administration (oral vs. topical)
- Ensure the product is actually approved for pediatric use
Pediatric Dosing Principles to Consider
If seeking guidance on any pediatric medication, remember that: 2, 3
- Children are not simply "small adults" - direct weight-based scaling from adult doses often results in inappropriate dosing 2
- Neonates and infants (<2 years) require special consideration due to immature drug elimination pathways 2, 3
- Children ≥2 years are physiologically mature and differ from adults primarily in size 2
- Body surface area (BSA) is generally more appropriate than weight-based dosing for children >6 months of age, except for specific drug classes 3
Common Pitfall
Do not attempt to use topical Collicaid orally. The product is designed for external use only and is contraindicated in young children even for its intended topical application. 1